Science and Research

Noninvasive prediction of pulmonary hemodynamics in chronic thromboembolic pulmonary hypertension by electrocardiogram-gated computed tomography

PURPOSE: The aim of the study was to investigate the potential of electrocardiogram (ECG)-gated computed tomography pulmonary angiography (CTPA) as a predictor of disease severity in patients with chronic thromboembolic pulmonary hypertension (CTEPH). METHOD: Forty-five CTEPH patients with a mean age of 63.8 years±12.7 y (±standard deviation) who had undergone ECG-gated CTPA and right heart catheterization (RHC) were included in the study. Right ventricular to left ventricular volume ratio (RVV/LVV), diameter ratio on 4-chamber view (RVD4CH/LVD4CH), pulmonary trunk (PT) diameter, PT to aortic diameter ratio (PT/A), and septal angle were correlated to mean pulmonary artery pressure (mPAP). Moreover, RVV/LVV and RVD4CH/LVD4CH were adjusted to pulmonary diameter index (PADi) and PT/A index. Areas under the curve (AUC) for predicting mPAP above 40 mmHg, 35 mmHg, and 30 mmHg were calculated. RESULTS: RVD4CH/LVD4CH revealed the strongest correlation to mPAP before (r = 0.6507) and after (r = 0.7650; p < 0.0001) PT/A adjustment. The AUCs for predicting pH with mPAP over 40 mmHg and 30 mmHg were 0.9229 and 0.864, respectively. A cutoff value of 1.298 enabled prediction of pH with mPAP over 40 mmHg with a sensitivity, specificity, positive predictive, and negative predictive value of 80.00 %, 95.83 %, 88.46 %, and 94.12 %, respectively. Intra- and interobserver variability were excellent for all parameters. CONCLUSION: Combining different and easily evaluable ECG-gated CTPA parameters enables excellent prediction of pulmonary hemodynamics in CTEPH patients. Ventricular diameter ratio on 4-chamber view adjusted by the PT/A ratio yielded the best correlation to mPAP.
  • Roller, F. C.
  • Yildiz, S. M.
  • Kriechbaum, S. D.
  • Harth, S.
  • Breithecker, A.
  • Liebetrau, C.
  • Schüßler, A.
  • Mayer, E.
  • Hamm, C. W.
  • Guth, S.
  • Krombach, G. A.
  • Wiedenroth, C. B.

Keywords

  • 4CH, four-chamber view
  • AUC, Area under the curve
  • CI, Confidence interval
  • CT, Computed tomography
  • Cteph
  • CTEPH, Chronic thromboembolic pulmonary hypertension
  • Ctpa
  • CTPA, Computed tomography pulmonary angiography
  • ECG, Electrocardiogram
  • HU, Hounsfield units
  • ICC, intra-class concordance correlation coefficient
  • LV, Left ventricular
  • LVD, Left ventricular diameter
  • LVV, Left ventricular volume
  • MDCT, Multidetector computed tomography
  • NPV, Negative predictive value
  • PADi, Pulmonary artery diameter index
  • PH, Pulmonary hypertension
  • PPV, Positive predictive value
  • PT, Pulmonary trunk
  • Pulmonary hypertension
  • RHC, Right heart catheterization
  • ROC, Receiver operating characteristics
  • RV, Right ventricular
  • RVD, Right ventricular diameter
  • RVV, Right ventricular volume
  • Right heart catheterization
  • SD, Standard deviation
  • mPAP, mean pulmonary artery pressure
  • Pharmaceuticals AG, Bayer AG, BTG, MSD, and Pfizer. SG has received speaker fees
  • from Actelion, Bayer, GSK, MSD and Pfizer. The other authors declare that they have
  • no competing interests.
Publication details
DOI: 10.1016/j.ejro.2021.100384
Journal: Eur J Radiol Open
Pages: 100384 
Work Type: Original
Location: UGMLC
Disease Area: PLI, PH
Partner / Member: JLU
Access-Number: 34712746

DZL Engagements

chevron-down